Loading financial statements…
Import this data to Google Sheets with:
=jivedata("UNH","financials")Full statements spill as a table. For one cell: =jivedata("UNH","Revenue") or =jivedata("UNH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
UNH • CIK 0000731766
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Operating Income (Loss) | $32,358,000 | $32,287,000 | $18,964,000 | $21,676,000 |
| Interest Expense | $3,246,000 | $3,906,000 | $4,002,000 | $3,894,000 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $29,112,000 | $20,071,000 | $14,697,000 | $17,440,000 |
| Income Tax Expense (Benefit) | $5,968,000 | $4,829,000 | $1,890,000 | $2,528,000 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $23,144,000 | $15,242,000 | $12,807,000 | $14,912,000 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $763,000 | $837,000 | $751,000 | $790,000 |
| Net Income (Loss) Attributable to Parent | $22,381,000 | $14,405,000 | $12,056,000 | $14,122,000 |
| Premiums Earned, Net | $290,827,000 | $308,810,000 | $352,229,000 | $352,307,000 |
| Investment Income, Interest and Dividend | $4,089,000 | $5,202,000 | $3,920,000 | $4,133,000 |
| Revenues | $371,622,000 | $400,278,000 | $447,567,000 | $450,129,000 |
| Policyholder Benefits and Claims Incurred, Net | — | $264,185,000 | $313,995,000 | $310,846,000 |
| Selling, General and Administrative Expense | $54,628,000 | $53,013,000 | $59,592,000 | $61,878,000 |
| Cost of Goods and Services Sold | $38,770,000 | $46,694,000 | $50,655,000 | $51,444,000 |
| Depreciation, Depletion and Amortization, Nonproduction | $3,972,000 | $4,099,000 | $4,361,000 | $4,285,000 |
| Costs and Expenses | $339,264,000 | $367,991,000 | $428,603,000 | $428,453,000 |
| Weighted Average Number of Shares Outstanding, Basic | 928,000,000 | 921,000,000 | 908,000,000 | 903,000,000 |
| Weighted Average Number Diluted Shares Outstanding Adjustment | 10,000,000 | 8,000,000 | 3,000,000 | 2,000,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 938,000,000 | 929,000,000 | 911,000,000 | 905,000,000 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 6,000,000 | 6,000,000 | 12,000,000 | 17,000,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $25,427,000 | $25,312,000 | $24,365,000 | $28,585,000 |
| Short-term Investments | $4,201,000 | $3,801,000 | $3,756,000 | $2,883,000 |
| Long-term Investments | $47,609,000 | $52,354,000 | $54,251,000 | $57,716,000 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $21,276,000 | $22,365,000 | $23,018,000 | $21,573,000 |
| Property, Plant and Equipment, Net | $11,450,000 | $10,553,000 | $10,762,000 | $10,762,000 |
| Other Receivables, Net, Current | $17,694,000 | $26,089,000 | $29,697,000 | $24,722,000 |
| Goodwill | $103,732,000 | $106,734,000 | $110,499,000 | $110,645,000 |
| Prepaid Expense and Other Assets, Current | $6,084,000 | $8,212,000 | $9,746,000 | $9,097,000 |
| Intangible Assets, Net (Excluding Goodwill) | $15,194,000 | $23,268,000 | $20,474,000 | $19,749,000 |
| Assets, Current | $78,437,000 | $85,779,000 | $90,582,000 | $86,860,000 |
| Other Assets, Noncurrent | $17,298,000 | $19,590,000 | $23,013,000 | $23,995,000 |
| Assets | $273,720,000 | $298,278,000 | $309,581,000 | $309,727,000 |
| Long-term Debt, Excluding Current Maturities | $58,263,000 | $72,359,000 | $72,320,000 | $69,501,000 |
| Deferred Income Tax Liabilities, Net | $3,021,000 | $3,620,000 | $2,421,000 | $2,722,000 |
| Other Liabilities, Noncurrent | $14,463,000 | $15,939,000 | $18,245,000 | $19,735,000 |
| Liabilities | $174,801,000 | $195,687,000 | $207,883,000 | $203,778,000 |
| Redeemable Noncontrolling Interest, Equity, Carrying Amount | $4,498,000 | $4,323,000 | $1,608,000 | $1,436,000 |
| Liability for Claims and Claims Adjustment Expense | $32,395,000 | $34,224,000 | $39,337,000 | $38,930,000 |
| Accounts Payable and Accrued Liabilities, Current | $31,958,000 | $34,337,000 | $38,032,000 | $39,741,000 |
| Debt, Current | $4,274,000 | $4,545,000 | $6,069,000 | $3,827,000 |
| Deferred Revenue, Current | $3,355,000 | $3,317,000 | $3,413,000 | $2,986,000 |
| Other Liabilities, Current | $27,072,000 | $27,346,000 | $28,046,000 | $26,336,000 |
| Liabilities, Current | $99,054,000 | $103,769,000 | $114,897,000 | $111,820,000 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $9,000 | $9,000 | $9,000 | $9,000 |
| Additional Paid in Capital | — | — | $559,000 | $0 |
| Retained Earnings (Accumulated Deficit) | $95,774,000 | $96,036,000 | $95,603,000 | $100,957,000 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-7,027,000 | $-3,387,000 | $-2,061,000 | $-2,519,000 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $5,665,000 | $5,610,000 | $5,980,000 | $6,066,000 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $94,421,000 | $98,268,000 | $100,090,000 | $104,513,000 |
| Accounts Receivable, Allowance for Credit Loss, Current | $1,000,000 | $985,000 | $1,208,000 | $1,208,000 |
| Allowance for Doubtful Other Receivables, Current | $2,084,000 | $2,864,000 | $3,763,000 | $3,763,000 |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $7,039,000 | $6,971,000 | $7,546,000 | $7,546,000 |
| Finite-Lived Intangible Assets, Accumulated Amortization | $7,279,000 | $8,350,000 | $7,472,000 | $7,472,000 |
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 3,000,000,000 | 3,000,000,000 | 3,000,000,000 | 3,000,000,000 |
| Common Stock, Shares, Issued | 924,000,000 | 915,000,000 | 906,000,000 | 905,000,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $23,144,000 | $15,242,000 | $12,807,000 | $14,912,000 |
| Net Cash Provided by (Used in) Operating Activities | $29,068,000 | $24,204,000 | $19,697,000 | $27,017,000 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $97,000 | $-61,000 | $40,000 | $8,000 |
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations | — | $104,000 | $-592,000 | $200,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $2,062,000 | $-115,000 | $-947,000 | $-11,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $25,427,000 | $25,312,000 | $24,365,000 | $21,649,000 |
| Depreciation, Depletion and Amortization, Nonproduction | $3,972,000 | $4,099,000 | $4,361,000 | $4,285,000 |
| Payments to Acquire Investments | $18,314,000 | $27,308,000 | $17,373,000 | $19,318,000 |
| Deferred Income Tax Expense (Benefit) | $-245,000 | $-296,000 | $-1,752,000 | $-1,254,000 |
| Proceeds from Sale of Debt Securities, Available-for-sale | $7,307,000 | $18,514,000 | $9,288,000 | $6,771,000 |
| Share-based Payment Arrangement, Noncash Expense | $1,059,000 | $1,018,000 | $971,000 | $1,023,000 |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $9,230,000 | $9,319,000 | $8,446,000 | $8,830,000 |
| Payments to Acquire Businesses, Net of Cash Acquired | $10,136,000 | $13,408,000 | $4,509,000 | $3,873,000 |
| Gain (Loss) on Disposition of Business | — | $3,333,000 | $910,000 | $910,000 |
| Payments to Acquire Property, Plant, and Equipment | $3,386,000 | $3,499,000 | $3,622,000 | $3,400,000 |
| Other Noncash Income (Expense) | $505,000 | $28,000 | $-1,673,000 | $-1,311,000 |
| Proceeds from Divestiture of Businesses | $685,000 | $2,041,000 | $561,000 | $1,543,000 |
| Payments for (Proceeds from) Other Investing Activities | $960,000 | $1,667,000 | $341,000 | $-1,476,000 |
| Net Cash Provided by (Used in) Investing Activities | $-15,574,000 | $-20,527,000 | $-8,685,000 | $-11,414,000 |
| Increase (Decrease) in Accounts Receivable | $3,114,000 | $1,437,000 | $764,000 | $-2,398,000 |
| Payments for Repurchase of Common Stock | $8,000,000 | $9,000,000 | $5,545,000 | $1,646,000 |
| Increase (Decrease) in Other Operating Assets | $2,444,000 | $4,140,000 | $4,606,000 | $-557,000 |
| Payments of Ordinary Dividends, Common Stock | $6,761,000 | $7,533,000 | $7,916,000 | $8,096,000 |
| Increase (Decrease) in Health Care Insurance Liabilities | $3,482,000 | $2,503,000 | $5,824,000 | $1,033,000 |
| Proceeds from Issuance of Common Stock | $1,353,000 | $1,846,000 | $827,000 | $605,000 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $3,516,000 | $2,463,000 | $1,665,000 | $3,297,000 |
| Repayments of Long-term Debt | $2,125,000 | $3,000,000 | $3,050,000 | $5,550,000 |
| Increase (Decrease) in Deferred Revenue | $203,000 | $-197,000 | $163,000 | $23,000 |
| Proceeds from (Repayments of) Commercial Paper | $11,000 | $-151,000 | $807,000 | $-103,000 |
| Proceeds from Issuance of Long-term Debt | $6,394,000 | $17,811,000 | $2,969,000 | $0 |
| Increase (Decrease) in Deposits | $-521,000 | $-1,560,000 | $366,000 | $723,000 |
| Payments for Repurchase of Redeemable Noncontrolling Interest | $730,000 | $280,000 | $165,000 | $165,000 |
| Proceeds from (Payments for) Other Financing Activities | $-1,150,000 | $-1,645,000 | $63,000 | $-1,179,000 |
| Net Cash Provided by (Used in) Financing Activities | $-11,529,000 | $-3,512,000 | $-11,644,000 | $-15,411,000 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $3,035,000 | $3,594,000 | $4,030,000 | $4,030,000 |
| Income Taxes Paid, Net | $6,078,000 | $4,620,000 | $3,714,000 | $3,714,000 |